Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

HER2 test showdown: which lab method works best for chinese cancer patients?

NCT ID NCT07404202

First seen Feb 11, 2026 · Last updated May 18, 2026 · Updated 12 times

Summary

This study looks at tumor samples from 2,100 Chinese patients with lung, gynecological, bile duct, or bladder cancers. Researchers will compare several HER2 testing methods to see if they give the same results. The goal is to improve accuracy and consistency in diagnosing HER2-positive cancers, which can guide treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAN-TUMOR(NSCLC, GYN CANCERS, BTC AND UC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Beijing, China

  • Research Site

    WITHDRAWN

    Changsha, China

  • Research Site

    RECRUITING

    Chengdu, China

  • Research Site

    RECRUITING

    Guangzhou, China

  • Research Site

    WITHDRAWN

    Guangzhou, China

  • Research Site

    NOT_YET_RECRUITING

    Guangzhou, China

  • Research Site

    RECRUITING

    Haerbin, China

  • Research Site

    RECRUITING

    Jinan, China

  • Research Site

    RECRUITING

    Nantong, China

  • Research Site

    NOT_YET_RECRUITING

    Shanghai, China

  • Research Site

    RECRUITING

    Shanghai, China

  • Research Site

    NOT_YET_RECRUITING

    Shenyang, China

  • Research Site

    WITHDRAWN

    Suzhou, China

  • Research Site

    NOT_YET_RECRUITING

    Ürümqi, China

Conditions

Explore the condition pages connected to this study.